Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate
CAS1208081-25-7
Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate (CAS 1208081-25-7, C7H10N2O3) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 1208081-25-7
- Formula
- C7H10N2O3
- Mol. weight
- 170.17 g/mol
Chemical Specifications
Identifiers
| CAS number | 1208081-25-7 |
|---|---|
| Product name | Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate |
| Chinese name | 3-(羟甲基)-1-甲基-1H-吡唑-5-羧酸甲酯 |
| Molecular formula | C7H10N2O3 |
| Molecular weight | 170.17 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate?
The CAS Registry Number of Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate is 1208081-25-7.
What is the molecular formula and molecular weight of Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate?
The molecular formula of Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate is C7H10N2O3, and its molecular weight is 170.17 g/mol.
How can I request a quotation for Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate?
Send an inquiry for Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate (CAS 1208081-25-7) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for Methyl 5-hydroxymethyl-2-methyl-2H-pyrazole-3-carboxylate
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.